296 posters, 7 videos, 13 audios, 14 topics, 10 sessions, 1,019 authors, 259 institutions
ePostersLive by SciGen Technologies S.A. All rights reserved.
RCOphth Annual Congress 2026
18 - 21 May, 2026 | Manchester Central, Manchester
P172
LUCE-1: A First-in-Human Phase I/II Trial of AAVB-081 Gene Therapy Using Dual AAV Platform in participants with Usher Syndrome Type 1B Retinitis Pigmentosa
Poster Presenter
Authors
Paulo Eduardo Stanga, Francesca Simonelli, Michel Michaelides, Kanmin Xue, Francesco Testa, Valentina di Iorio, Chrysanthi Tsika, Robert Henderson, Jayashree Sahni, Ioulietta Mulligan, Natalia Misciatelli, Ekaterini Kotsopoulou, Michele Della Corte, Paolo Melillo, Settimio Rossi, Alberto Aurrichio
Affiliations
The Retina Clinic London (London), Multidisciplinary Department of Medical, Surgical and Dental Sciences, University of Campania Luigi Vanvitelli (Naples), Moorfields Eye Hospital NHS Foundation Trust (London), Moorfields Eye Hospital NHS Foundation Trust (London); Great Ormond Street Hospital (London), AAVantgarde Bio, AAVantgarde Bio; Telethon Institute of Genetics and Medicine (Naples); Department of Advanced Biomedical Sciences, “Federico II” University (Naples
Part of Topic
Medical retina
LUCE-1: A First-in-Human Phase I/II Trial of AAVB-081 Gene Therapy Using Dual AAV Platform in participants with Usher Syndrome Type 1B Retinitis Pigmentosa